D. E. Shaw & Co., Inc. Arvinas, Inc. Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 2,150,730 shares of ARVN stock, worth $20.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,150,730

Holding current value

$20.9 Million

% of portfolio

0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.07 - $9.62 $13.1 Million - $20.7 Million	2,150,730 New	2,150,730 $15.8 Million
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $4.43 Million - $6.13 Million	-187,227 Reduced 83.45%	37,124 $914,000
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $1.94 Million - $3.2 Million	-79,287 Reduced 26.11%	224,351 $5.97 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $7.96 Million - $11.4 Million	218,707 Added 257.51%	303,638 $12.5 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $910,018 - $2.71 Million	64,131 Added 308.32%	84,931 $3.5 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $408,512 - $586,768	20,800 New	20,800 $408,000
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $295,602 - $409,409	-7,060 Reduced 52.54%	6,377 $284,000
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $242,275 - $499,486	-6,728 Reduced 33.36%	13,437 $566,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $2.47 Million - $3.34 Million	-40,953 Reduced 67.01%	20,165 $1.36 Million
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $6.22 Million - $9.09 Million	-94,531 Reduced 60.73%	61,118 $5.02 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $3.03 Million - $4.46 Million	41,392 Added 36.23%	155,649 $12.8 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $1.39 Million - $1.94 Million	-23,065 Reduced 16.8%	114,257 $8.8 Million
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $3.95 Million - $6.21 Million	67,964 Added 97.99%	137,322 $9.08 Million
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $119,383 - $502,191	-5,913 Reduced 7.86%	69,358 $5.89 Million
Q3 2020 Nov 16, 2020	SELL	$22.99 - $36.34 $1.93 Million - $3.06 Million	-84,112 Reduced 52.77%	75,271 $1.78 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $1.18 Million - $2.24 Million	39,473 Added 32.92%	159,383 $5.35 Million
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $329,109 - $543,528	9,973 Added 9.07%	119,910 $4.83 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $1.69 Million - $4.88 Million	109,937 New	109,937 $4.52 Million

Others Institutions Holding ARVN

# of Institutions

246

Shares Held

68.2M

Call Options Held

2.99M

Put Options Held

534K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $517M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account